Unproven stem cell interventions: A global public health problem requiring global deliberation

Stem Cell Reports. 2021 Jun 8;16(6):1435-1445. doi: 10.1016/j.stemcr.2021.05.004.

Abstract

The unproven stem cell intervention (SCI) industry is a global health problem. Despite efforts of some nations, the industry continues to flourish. In this paper, we call for a global approach and the establishment of a World Health Organization (WHO) Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. The WHO committee can harmonize national regulations; promote regulatory approaches responsive to unmet patient needs; and formulate an education campaign against misinformation. Fostering an international dialog and developing recommendations that can be adopted by member states would effectively address the global market of unproven SCIs.

Keywords: World Health Organization; global health; patient views; regenerative medicine; regulations; unproven stem cell interventions.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Government Regulation*
  • Health Policy / legislation & jurisprudence*
  • Humans
  • Public Health / ethics
  • Public Health / legislation & jurisprudence*
  • Regenerative Medicine / legislation & jurisprudence*
  • Stem Cell Transplantation / ethics
  • Stem Cell Transplantation / legislation & jurisprudence*
  • World Health Organization